Dapagliflozin Prescribing at THE DE PARYS GROUP
Drugs used in diabetes | Endocrine System
Items (12m)
8,275
Total Quantity
344.0K
NHS Cost
£425.6K
vs National Avg
+560.8%
THE DE PARYS GROUP prescribed 8,275 items of Dapagliflozin over the last 12 months at a cost of £425,628 to the NHS. This is 560.8% above the national average prescribing rate. Dapagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
640
Jun 2026
639
Jun 2026
631
Jun 2026
684
Jun 2026
657
Jun 2026
705
Jun 2026
685
Jun 2026
767
Jun 2026
762
Jun 2026
647
Jun 2026
748
Jun 2026
710
Prescribing Details
| Total Items | 8,275 |
|---|---|
| Total Quantity | 343,967 |
| Total NHS Cost | £425,628 |
| Presentations | 2 different forms |
| vs National Average | +560.8% |
Dapagliflozin Prescribing Comparison
| This practice | 8,275 items |
|---|---|
| National average per practice | 1,252 items |
| Difference | +560.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.